Metabolic disease models – Diet-induced Obesity DIO Mouse Model
Study the efficacy of your novel anti-obesity therapeutics using the DIO mouse model
DIO Mouse Model Characteristics
The diet-induced obesity DIO mouse model represents a physiological approach to studying efficacy of novel compounds against obesity and related metabolic disorders in a preclinical research setting. Maintaining C57BL/6N mice on a Western-style high-fat diet (HFD) comprising 60% fat content, the DIO mouse model develops many hallmarks of metabolic disease such as obesity, insulin sensitivity, elevated fasting blood glucose and insulin resistance. Additionally, using various behavioral phenotyping protocols, at InnoSer we have demonstrated that HF-fed mice show substantial reduction in general activity, nest building capacity as well as memory performance (e.g., during behavioral tests such as Morris Water Maze [MWM]).
Depending on study timelines, this model can be adapted to study varying stages of metabolic dysfunction, including pre-diabetes, type 2 diabetes mellitus (T2DM) and more severe insulin resistance in the setting of Western diet and obesity. Unlike genetic metabolic models such as the db/db mouse model, the DIO model reflects lifestyle-induced obesity seen in humans, providing you with a highly translational mouse model to study efficacy of novel anti-obesity strategies. Combined with InnoSer’s expertise in behavioral neuroscience studies, the DIO mouse model is also suitable to evaluate efficacy of compounds against metabolic disease-associated cognitive dysfunctions which is currently an emerging area of research within the metabolic disease field. Contact us today to discuss how this model can support your research objectives in preclinical metabolic health research.
✓ Mouse model of physiological induction of obesity
✓ Mice show key hallmarks of metabolic disease (obesity, insulin resistance, hyperglycemia)

As a preclinical metabolic CRO, InnoSer’s team delivers you with a range of high-quality in vivo models for key metabolic diseases with different associated risk factors and aetiologias. This selection allows you to test therapeutic efficacy to prevent or reverse insulin resistance, pre-diabetes, obesity type 2 diabetes mellitus (T2DM), and/or MAFLD/MASH (NASH/NAFLD). To study metabolic disease-associated cardiovascular complications and cardiac dysfunction, InnoSer recommends the use of the Western diet-induced diabetic cardiomyopathy rat model. Reach out to our team to discuss the most suitable model to answer your research questions.
DIO Mouse Model Sample Data

The diet-induced obesity DIO mouse is a relevant research tool to study efficacy of compounds against various metabolic-disease conditions.
Long-term body weight following 20-week diet. HF mice were significantly heavier compared to chow-fed mice and HFCF mice, whereas HFCF mice were significantly heavier compared to chow fed mice.

The diet-induced obesity DIO mouse is a relevant research tool to study efficacy of compounds against various metabolic-disease conditions, including associated cognitive dysfunctions.
Although these data may indicate that HF diet and HFCF mice show a cognitive deficit in this test, the vast reduction in overall activity (data not shown) in comparison to Chow-fed mice impacts this test.

The diet-induced obesity DIO mouse is a relevant research tool to study efficacy of compounds against various metabolic-disease conditions, including associated cognitive dysfunctions.
HF diet and HFCF mice make fewer entries through the CognitionWallTM in comparison to Chow-fed mice.
DIO Mouse Model Readouts
The People Behind Your Research
Yanick Fanton, PhD, Chief Scientific Officer
As Chief Science Officer at InnoSer, Yanick is responsible for all customer studies at InnoSer and takes care of the scientific and technical coordination.
Discover Other Related Metabolic Disease Mouse Models
Stay Curious: More Articles to Explore
AAALAC Accreditation
InnoSer has earned the AAALAC accreditation, demonstrating our commitment to responsible animal care and use. AAALAC International is a nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Our accreditation is valid for three years, incl. 2023. Read more about the AAALAC accreditation programme here.
Animal Welfare
The 3Rs impact everything from policy and regulatory change to the development and uptake of new technologies and approaches. This is why InnoSer has ongoing commitment and monitoring of these processes. The steps we practice maximize our ability to replace, reduce and refine animal involvement and facilitate our commitment to these principles when it comes to research and drug development.
info@innoserlaboratories.com